nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—blood plasma—schizophrenia	0.0256	0.101	CbGeAlD
Trametinib—MAP2K1—forebrain—schizophrenia	0.0159	0.0626	CbGeAlD
Trametinib—MAP2K1—telencephalon—schizophrenia	0.0146	0.0576	CbGeAlD
Trametinib—MAP2K2—forebrain—schizophrenia	0.014	0.0551	CbGeAlD
Trametinib—MAP2K2—telencephalon—schizophrenia	0.0129	0.0507	CbGeAlD
Trametinib—MAP2K1—gonad—schizophrenia	0.0122	0.048	CbGeAlD
Trametinib—CYP3A4—urine—schizophrenia	0.0115	0.0452	CbGeAlD
Trametinib—MAP2K2—gonad—schizophrenia	0.0107	0.0423	CbGeAlD
Trametinib—MAP2K1—blood—schizophrenia	0.0106	0.0419	CbGeAlD
Trametinib—MAP2K2—blood—schizophrenia	0.00936	0.0369	CbGeAlD
Trametinib—MAP2K2—midbrain—schizophrenia	0.00924	0.0364	CbGeAlD
Trametinib—MAP2K1—endocrine gland—schizophrenia	0.00922	0.0363	CbGeAlD
Trametinib—CYP2C8—blood plasma—schizophrenia	0.00885	0.0348	CbGeAlD
Trametinib—MAP2K1—nervous system—schizophrenia	0.00863	0.034	CbGeAlD
Trametinib—MAP2K1—central nervous system—schizophrenia	0.00831	0.0327	CbGeAlD
Trametinib—MAP2K1—cerebellum—schizophrenia	0.00812	0.032	CbGeAlD
Trametinib—MAP2K2—endocrine gland—schizophrenia	0.00812	0.032	CbGeAlD
Trametinib—MAP2K2—nervous system—schizophrenia	0.0076	0.0299	CbGeAlD
Trametinib—MAP2K2—central nervous system—schizophrenia	0.00732	0.0288	CbGeAlD
Trametinib—MAP2K2—cerebellum—schizophrenia	0.00715	0.0282	CbGeAlD
Trametinib—MAP2K1—brain—schizophrenia	0.0066	0.026	CbGeAlD
Trametinib—CYP3A4—blood plasma—schizophrenia	0.00599	0.0236	CbGeAlD
Trametinib—MAP2K2—brain—schizophrenia	0.00581	0.0229	CbGeAlD
Trametinib—CYP2C8—blood—schizophrenia	0.00324	0.0128	CbGeAlD
Trametinib—CYP2C8—endocrine gland—schizophrenia	0.00281	0.0111	CbGeAlD
Trametinib—CYP3A4—blood—schizophrenia	0.0022	0.00865	CbGeAlD
Trametinib—CYP2C8—brain—schizophrenia	0.00201	0.00792	CbGeAlD
Trametinib—CYP3A4—endocrine gland—schizophrenia	0.0019	0.0075	CbGeAlD
Trametinib—CYP3A4—nervous system—schizophrenia	0.00178	0.00702	CbGeAlD
Trametinib—CYP3A4—central nervous system—schizophrenia	0.00172	0.00676	CbGeAlD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—AKT1—schizophrenia	0.000116	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—AKT1—schizophrenia	0.000116	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TLE1—schizophrenia	0.000115	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NRG3—schizophrenia	0.000115	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—AKT1—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—AKT1—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—AKT1—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—AKT1—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-E—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SNAP25—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—AKT1—schizophrenia	0.000115	0.000154	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000114	0.000153	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—AKT1—schizophrenia	0.000114	0.000153	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000114	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GFAP—schizophrenia	0.000114	0.000153	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000113	0.000152	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PNP—schizophrenia	0.000113	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—AKT1—schizophrenia	0.000113	0.000152	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.000113	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GRM5—schizophrenia	0.000113	0.000151	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—AKT1—schizophrenia	0.000113	0.000151	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—GSK3B—schizophrenia	0.000113	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—AKT1—schizophrenia	0.000112	0.000151	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FOS—schizophrenia	0.000112	0.00015	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCK—schizophrenia	0.00011	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HSPA1A—schizophrenia	0.00011	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRL—schizophrenia	0.00011	0.000147	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS1—schizophrenia	0.000109	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TLE3—schizophrenia	0.000109	0.000146	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—AKT1—schizophrenia	0.000109	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—AKT1—schizophrenia	0.000108	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—AKT1—schizophrenia	0.000108	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—AKT1—schizophrenia	0.000108	0.000145	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDE4B—schizophrenia	0.000107	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—AKT1—schizophrenia	0.000107	0.000143	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—AKT1—schizophrenia	0.000106	0.000142	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCKAR—schizophrenia	0.000106	0.000142	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—AKT1—schizophrenia	0.000105	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—GSK3B—schizophrenia	0.000105	0.000141	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NDUFV2—schizophrenia	0.000105	0.000141	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000105	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FOS—schizophrenia	0.000105	0.00014	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000104	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCK—schizophrenia	0.000103	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HSPA1A—schizophrenia	0.000103	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRL—schizophrenia	0.000103	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADORA2A—schizophrenia	0.000102	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—S100B—schizophrenia	0.000102	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS1—schizophrenia	0.000102	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	0.000102	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—AKT1—schizophrenia	0.000102	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.000101	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PRL—schizophrenia	0.000101	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000101	0.000135	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDE4B—schizophrenia	0.0001	0.000135	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIP4K2A—schizophrenia	9.9e-05	0.000133	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCKAR—schizophrenia	9.89e-05	0.000133	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRODH—schizophrenia	9.84e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGA—schizophrenia	9.82e-05	0.000132	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	9.82e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB4—schizophrenia	9.79e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADORA2A—schizophrenia	9.59e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—S100B—schizophrenia	9.58e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ATP2A2—schizophrenia	9.57e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPY—schizophrenia	9.57e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH4—schizophrenia	9.57e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	9.55e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PRL—schizophrenia	9.49e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PLA2G4A—schizophrenia	9.43e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OXT—schizophrenia	9.24e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1B—schizophrenia	9.24e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGA—schizophrenia	9.19e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB4—schizophrenia	9.16e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB4—schizophrenia	9.04e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NRG1—schizophrenia	9.04e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH4—schizophrenia	8.96e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPY—schizophrenia	8.96e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ATP2A2—schizophrenia	8.96e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MEF2C—schizophrenia	8.96e-05	0.00012	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP26B1—schizophrenia	8.95e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—schizophrenia	8.92e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1A—schizophrenia	8.89e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPS—schizophrenia	8.76e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—YWHAZ—schizophrenia	8.66e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OXT—schizophrenia	8.64e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1B—schizophrenia	8.64e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2C—schizophrenia	8.59e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD1—schizophrenia	8.59e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB3—schizophrenia	8.46e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB4—schizophrenia	8.46e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NRG1—schizophrenia	8.45e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EP300—schizophrenia	8.39e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MEF2C—schizophrenia	8.38e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NTRK2—schizophrenia	8.35e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NRG1—schizophrenia	8.34e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—schizophrenia	8.34e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1A—schizophrenia	8.32e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD3—schizophrenia	8.32e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPS—schizophrenia	8.19e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—YWHAZ—schizophrenia	8.1e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD4—schizophrenia	8.07e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD1—schizophrenia	8.03e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2C—schizophrenia	8.03e-05	0.000108	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MPC2—schizophrenia	8.02e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K2—Disease—YWHAZ—schizophrenia	7.99e-05	0.000107	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TPH1—schizophrenia	7.98e-05	0.000107	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCLM—schizophrenia	7.98e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB3—schizophrenia	7.92e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—schizophrenia	7.85e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EP300—schizophrenia	7.85e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB3—schizophrenia	7.82e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK2—schizophrenia	7.81e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NRG1—schizophrenia	7.81e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD3—schizophrenia	7.78e-05	0.000104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CNR1—schizophrenia	7.71e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD4—schizophrenia	7.55e-05	0.000101	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	7.52e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD2—schizophrenia	7.52e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR7—schizophrenia	7.52e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—schizophrenia	7.51e-05	0.000101	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PRKD1—schizophrenia	7.5e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K1—Disease—YWHAZ—schizophrenia	7.48e-05	0.0001	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCH2—schizophrenia	7.46e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EP300—schizophrenia	7.41e-05	9.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—schizophrenia	7.35e-05	9.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB3—schizophrenia	7.31e-05	9.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CNR1—schizophrenia	7.21e-05	9.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRL—schizophrenia	7.1e-05	9.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR7—schizophrenia	7.04e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD2—schizophrenia	7.04e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—schizophrenia	7.03e-05	9.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NDST3—schizophrenia	7.01e-05	9.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—schizophrenia	6.99e-05	9.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EP300—schizophrenia	6.93e-05	9.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOA1—schizophrenia	6.91e-05	9.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—schizophrenia	6.81e-05	9.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACSL6—schizophrenia	6.65e-05	8.91e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC27A5—schizophrenia	6.65e-05	8.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRL—schizophrenia	6.64e-05	8.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—S100B—schizophrenia	6.62e-05	8.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—GSK3B—schizophrenia	6.56e-05	8.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—schizophrenia	6.54e-05	8.77e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FOS—schizophrenia	6.52e-05	8.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOA1—schizophrenia	6.47e-05	8.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—schizophrenia	6.37e-05	8.54e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DAO—schizophrenia	6.34e-05	8.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB4—schizophrenia	6.33e-05	8.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GAPDH—schizophrenia	6.26e-05	8.39e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CLOCK—schizophrenia	6.21e-05	8.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—S100B—schizophrenia	6.19e-05	8.3e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.19e-05	8.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—GSK3B—schizophrenia	6.14e-05	8.23e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.12e-05	8.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FOS—schizophrenia	6.1e-05	8.17e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PNP—schizophrenia	6.08e-05	8.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GSK3B—schizophrenia	6.06e-05	8.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TPH2—schizophrenia	6.05e-05	8.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNB2—schizophrenia	6.05e-05	8.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLA2G4A—schizophrenia	5.95e-05	7.98e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DPYD—schizophrenia	5.95e-05	7.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB4—schizophrenia	5.92e-05	7.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NRG1—schizophrenia	5.84e-05	7.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MEF2C—schizophrenia	5.79e-05	7.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GSK3B—schizophrenia	5.67e-05	7.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NDUFV2—schizophrenia	5.65e-05	7.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—YWHAZ—schizophrenia	5.6e-05	7.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLA2G4A—schizophrenia	5.57e-05	7.46e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNA1C—schizophrenia	5.53e-05	7.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB3—schizophrenia	5.47e-05	7.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NRG1—schizophrenia	5.47e-05	7.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MEF2C—schizophrenia	5.42e-05	7.26e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3C2A—schizophrenia	5.39e-05	7.23e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIP4K2A—schizophrenia	5.31e-05	7.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—schizophrenia	5.27e-05	7.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—YWHAZ—schizophrenia	5.24e-05	7.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB3—schizophrenia	5.12e-05	6.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—schizophrenia	5.07e-05	6.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—schizophrenia	4.93e-05	6.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—schizophrenia	4.9e-05	6.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—schizophrenia	4.84e-05	6.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2D6—schizophrenia	4.83e-05	6.48e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SNAP25—schizophrenia	4.83e-05	6.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—schizophrenia	4.83e-05	6.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	4.81e-05	6.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—schizophrenia	4.74e-05	6.36e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ESR1—schizophrenia	4.68e-05	6.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—schizophrenia	4.58e-05	6.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—schizophrenia	4.53e-05	6.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—schizophrenia	4.52e-05	6.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—schizophrenia	4.48e-05	6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ESR1—schizophrenia	4.37e-05	5.86e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP1A2—schizophrenia	4.37e-05	5.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—schizophrenia	4.32e-05	5.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TH—schizophrenia	4.31e-05	5.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCLM—schizophrenia	4.28e-05	5.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TPH1—schizophrenia	4.28e-05	5.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GSK3B—schizophrenia	4.24e-05	5.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—schizophrenia	4.19e-05	5.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—schizophrenia	4.04e-05	5.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRKD1—schizophrenia	4.03e-05	5.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—schizophrenia	3.99e-05	5.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GSK3B—schizophrenia	3.97e-05	5.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—schizophrenia	3.73e-05	5e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—COMT—schizophrenia	3.66e-05	4.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTP1—schizophrenia	3.65e-05	4.89e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOA—schizophrenia	3.64e-05	4.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.53e-05	4.73e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCB1—schizophrenia	3.45e-05	4.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GAPDH—schizophrenia	3.36e-05	4.51e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G4A—schizophrenia	3.35e-05	4.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—schizophrenia	3.35e-05	4.49e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CLOCK—schizophrenia	3.33e-05	4.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TPH2—schizophrenia	3.25e-05	4.35e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNB2—schizophrenia	3.25e-05	4.35e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DPYD—schizophrenia	3.19e-05	4.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	2.97e-05	3.98e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—schizophrenia	2.96e-05	3.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	2.89e-05	3.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—schizophrenia	2.85e-05	3.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—schizophrenia	2.79e-05	3.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—schizophrenia	2.76e-05	3.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—schizophrenia	2.73e-05	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—schizophrenia	2.67e-05	3.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—schizophrenia	2.61e-05	3.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—schizophrenia	2.61e-05	3.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.6e-05	3.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SNAP25—schizophrenia	2.6e-05	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—schizophrenia	2.44e-05	3.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—schizophrenia	2.41e-05	3.23e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.35e-05	3.15e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TH—schizophrenia	2.31e-05	3.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—schizophrenia	2.25e-05	3.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—schizophrenia	2e-05	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COMT—schizophrenia	1.97e-05	2.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTP1—schizophrenia	1.96e-05	2.62e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOA—schizophrenia	1.95e-05	2.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—schizophrenia	1.87e-05	2.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCB1—schizophrenia	1.85e-05	2.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.8e-05	2.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—schizophrenia	1.8e-05	2.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—schizophrenia	1.69e-05	2.26e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—schizophrenia	1.59e-05	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—schizophrenia	1.58e-05	2.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—schizophrenia	1.57e-05	2.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—schizophrenia	1.48e-05	1.98e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—schizophrenia	1.46e-05	1.96e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—schizophrenia	9.5e-06	1.27e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—schizophrenia	8.43e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—schizophrenia	5.1e-06	6.83e-06	CbGpPWpGaD
